Abstract Background Triple-negative breast cancer (TNBC) is highly aggressive with an increased metastatic incidence compared to other breast cancer subtypes. However. due to the absence of clinically reliable biomarkers and targeted therapy in TNBC. outcomes are suboptimal. https://parisnaturalfoodes.shop/product-category/micronized-creatine-powder/